If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
JANUVIA sitagliptin 100mg (as phosphate monohydrate) tablet blister pack AUST R: 133182Active ingredients:
sitagliptin phosphate monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd
Phone:
0289888000
|
Deletion from market:
31 Jan 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Manufacturing
Management action:
This product will be replaced with an alternative ARTG product - JANUVIA sitagliptin 100 mg (as phosphate monohydrate) tablet blister pack AUST R 408435
|
JANUVIA sitagliptin 25mg (as phosphate monohydrate) tablet blister pack AUST R: 133188Active ingredients:
sitagliptin phosphate monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd
Phone:
0289888000
|
Deletion from market:
31 Jan 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Manufacturing
Management action:
This product will be replaced with an alternative ARTG product - JANUVIA sitagliptin 25 mg (as phosphate monohydrate) tablet blister pack AUST R 408437
|
JANUVIA sitagliptin 50mg (as phosphate monohydrate) tablet blister pack AUST R: 133187Active ingredients:
sitagliptin phosphate monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd
Phone:
0289888000
|
Deletion from market:
31 Jan 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Manufacturing
Management action:
This product will be replaced with an alternative ARTG product - JANUVIA sitagliptin 50 mg (as phosphate monohydrate) tablet blister pack AUST R 408436
|
XELEVIA sitagliptin (as phosphate monohydrate) 100 mg film-coated tablet blister pack AUST R: 220107Active ingredients:
sitagliptin phosphate monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd
Phone:
0289888000
|
Deletion from market:
09 Jan 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Manufacturing
Management action:
This product will be replaced with an alternative ARTG product - XELEVIA sitagliptin 100 mg (as phosphate monohydrate) tablet blister pack AUST R 408438
|
XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack AUST R: 220109Active ingredients:
sitagliptin phosphate monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd
Phone:
0289888000
|
Deletion from market:
31 Jan 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Manufacturing
Management action:
This product will be replaced with an alternative ARTG product - XELEVIA sitagliptin 25 mg (as phosphate monohydrate) tablet blister pack AUST R 408440
|
XELEVIA sitagliptin (as phosphate monohydrate) 50 mg film-coated tablet blister pack AUST R: 220108Active ingredients:
sitagliptin phosphate monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd
Phone:
0289888000
|
Deletion from market:
31 Jan 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Manufacturing
Management action:
This product will be replaced with an alternative ARTG product - XELEVIA sitagliptin 50 mg (as phosphate monohydrate) tablet blister pack AUST R 408439
|